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Abstract
Whilst associations between polygenic risk scores (PRSs) for schizophrenia and various phenotypic outcomes have
been reported, an understanding of developmental pathways can only be gained by modelling comorbidity across
psychopathology. We examine how genetic risk for schizophrenia relates to adolescent psychosis-related and
internalizing psychopathology using a latent modelling approach, and compare this to genetic risk for other
psychiatric disorders, to gain a more comprehensive understanding of the developmental pathways at this age. PRSs
for schizophrenia, major depressive disorder, neuroticism and bipolar disorder were generated for individuals in the
Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort. Multivariate linear regression was used to
examine the relationships of these PRSs with psychopathology factors modelled within (i) a correlated factors structure
and (ii) a bifactor structure. The schizophrenia PRS was associated with an increase in factors describing psychotic
experiences, negative dimension, depression and anxiety, but, when modelling a general psychopathology factor
based on these measures, speciﬁc effects above this persisted only for the negative dimension. Similar factor
relationships were observed for the neuroticism PRS, with a (weak) speciﬁc effect only for anxiety once modelling
general psychopathology. Psychopathology during adolescence can be described by a general psychopathology
construct that captures common variance as well as by speciﬁc constructs capturing remaining non-shared variance.
Schizophrenia risk genetic variants identiﬁed through genome-wide association studies mainly index negative rather
than positive symptom psychopathology during adolescence. This has potentially important implications both for
research and risk prediction in high-risk samples.
Introduction
Most psychiatric disorders are of complex multifactorial
aetiology1, with genome-wide association studies
(GWASs) indicating that multiple loci contribute to the
aetiology of schizophrenia, bipolar disorder, depression
and anxiety disorders, with evidence, provided by family
and GWA studies, of partly shared genetic effects2–12.
Studying the phenotypic manifestations of genetic lia-
bility for psychiatric disorders in the general population
can provide an understanding of the developmental
pathways and risk prediction. Although individual loci
have small effects on risk, cumulatively, alleles on current
GWAS platforms explain a substantial proportion of
genetic variation13,14. Information from even moderately
associated alleles can be collapsed into a single polygenic
risk score (PRS) that can be used to explore how genetic
risk is manifested early during development15.
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We previously examined the psychopathological fea-
tures associated with early expression of genetic risk for
schizophrenia in a large birth-cohort study, and found
strong evidence that a schizophrenia PRS was associated
with negative symptoms and anxiety during adolescence,
but only very weak evidence of association with psychotic
experiences at this age16. However, we were not able to
tease out comorbidity across disorders, nor deal with
measurement error that might explain the weaker evi-
dence of association with psychotic experiences than with
negative symptoms or anxiety.
One approach to address these limitations is to use
conﬁrmatory factor analysis (CFA) to explore the struc-
ture of psychopathology in a latent modelling framework.
Such analyses can be used to estimate the co-variance
between psychopathologies and effectively model the
measurement error present in the data. In the CFA
approach, error variance is separated from the shared
variance that is thought to be due to the underlying
construct. As a consequence, a resultant latent variable is
considered to be a more precise depiction of a phenotype
than either its manifest variables or a sum-score derived
from them17,18. One such latent modelling framework
used to investigate the common symptom structures of
psychological domains is the bifactor model, also known
as the general-speciﬁc model19–21. Bifactor models reﬂect
the notion that variability in a speciﬁc item response may
be due to multiple underlying sources rather than the true
score plus error approach considered in standard latent
trait modelling. For example, Caspi et al.19 describe a
general psychopathology (p) factor, analogous to the g
factor of general intelligence, which captures common-
alities between externalizing, internalizing, and thought
disorder symptoms. This general psychopathology factor
has been suggested to reﬂect shared elements of psy-
chiatric disorder aetiology, including genetic
vulnerability22,23.
A systematic review of the phenotypic correlational
structure from behavioural genetic studies provides sup-
port for a hierarchical structure of ﬁrst- and higher-order
dimensions of psychopathology24. Given that genetic
effects on psychopathology are likely to consist of both
highly pleiotropic and dimension-speciﬁc effects, studying
such effects will be enhanced through modelling such a
hierarchical structure compared to examining speciﬁc
disorders as outcomes24. This approach is consistent with
the cross-cutting approach described by the NIMH RDoC
initiative towards mental health research25, though also
posits that gains in knowledge can result from studying
higher-order constructs of psychopathology. Under-
standing heterogeneity can be further enhanced by com-
paring effects of multiple exposures within such a
hierarchical model to understand the different patterns of
exposure risk related to dimensions of psychopathology24.
We therefore aimed to use a latent modelling frame-
work to: (i) determine which type of latent model,
including a bifactor model, best describes the pattern of
psychosis-related and internalizing psychopathology dur-
ing adolescence in the general population, (ii) examine
how genetic risk for schizophrenia relates to the latent
constructs described within such a model (hence
addressing issues of comorbidity and measurement error
that limited previous interpretations of our data), and (iii)
examine whether the pattern of associations for schizo-
phrenia genetic risk is similar, or different, to that of
genetic risk for neuroticism, depression and bipolar
disorder.
Methods and materials
Participants
The sample comprised of individuals (initially 14,062
children) within the Avon Longitudinal Study of Parents
and Children (ALSPAC) birth cohort (www.alspac.bris.ac.
uk, see http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary for all available data)26,27. All sub-
jects provided written informed consent, and ethical
approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees.
To maximize sample size, and to limit the inﬂuence of
age or measurement source, psychopathology measures
were assessed using responses to self-report items as close
as possible to age 16 years.
Measures
Psychotic experiences
Ten items from the self-report Psychosis-Like Symp-
toms Questionnaire (PLIKS-Q)28 at age 16.5 years, rated
on a 3-point scale (never; maybe; deﬁnitely), were used to
indicate a psychotic experiences latent factor. Items
assessed presence of hallucinations, delusions and
thought interference since age 15 (see Supplementary
Table 1 for more details of all measures).
Negative dimension
Eleven items from the negative symptom subscale of the
validated29,30 Community Assessment of Psychic Experi-
ences (CAPE) self-report questionnaire at age 16.5 years,
rated on a 4-point scale (never; sometimes; often; nearly
always), were used to indicate a negative dimension latent
factor, representing the negative or “loss of function”
symptoms associated with psychosis such as apathy,
anergia and asociality. Items used measured the symp-
toms experienced in the past month.
Depression
Thirteen self-report items (rated as not true; sometimes
true; true) from the Mood and Feelings Questionnaire
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(MFQ)31 measuring past 2-weeks depressive symptoms at
age 16.5 years were used to indicate a depression latent
factor.
Anxiety
Anxiety items were taken from the semi-structured
Development and Well Being Assessment (DAWBA)
questionnaire at age 15.5 years, a valid instrument in
community and clinical samples32. Seventeen items rela-
ted to past-month generalized anxiety disorder and
agoraphobia were used to indicate an anxiety latent factor.
Polygenic risk scores
Following quality control and imputation, genetic data
were available for 8252 unrelated individuals (further
details in Supplementary Methods). PRSs for schizo-
phrenia, major depressive disorder (MDD), neuroticism
and bipolar disorder were constructed, as described pre-
viously13,16, using GWAS summary statistics from dis-
covery studies33–36 (Table 1).
PRSs were calculated for each ALSPAC individual using
PLINK (v1.07)37 by summing the number of risk alleles
for each single nucleotide polymorphism (SNP) weighted
by its discovery sample effect size (further details in
Supplementary Methods). Our primary analysis used
standardized scores generated from a list of SNPs with a
GWAS discovery sample P-value threshold (PT) ≤ 0.05.
Correlations between PRSs at PT ≤ 0.05 ranged from
−0.031 to 0.195 (Supplementary Table 2). As a secondary
analysis, PRSs were also generated using SNPs meeting
0.5, 1e−5, and genome-wide level P-value thresholds. For
all discovery studies, genome-wide signiﬁcance was
deﬁned as P ≤ 5e−8, with the exception of the MDD dis-
covery study34 where P ≤ 1e−8 was considered genome-
wide signiﬁcant due to the 15 million SNPs in the data
used within the study from 23andMe, Inc., a personal
genetics company.
Statistical analyses
Statistical analyses were conducted using Mplus (ver-
sion 7.31)38. Individuals were included in the analysis if
they had taken part in all psychopathology measures (N=
3650). The analysis sample was more likely to be female
and came from more advantaged backgrounds (Supple-
mentary Table 3).
Ordinal items from each questionnaire (PLIKS-Q,
CAPE, MFQ and DAWBA) were used as indicators of
latent constructs. To explore the dimensional structure of
the items and the relationship between psychotic experi-
ences, negative dimension items, depression and anxiety,
four measurement models were estimated and compared
(Fig. 1): (i) four uncorrelated latent variables for psychotic
experiences, negative dimension, anxiety and depression,
(ii) a unidimensional model consisting of a single latent
variable corresponding to a common general psycho-
pathological trait, (iii) four correlated latent variables for
psychotic experiences, negative dimension, anxiety and
depression and (iv) a bifactor model consisting of a single
latent variable corresponding to an underlying uni-
dimensional general psychopathological trait and four
speciﬁc latent variables for psychotic experiences, nega-
tive dimension, anxiety and depression.
Mean and variance-adjusted weighted least squares
(WLSMV) estimation was used to estimate each model18.
Absolute model ﬁt was evaluated using the root mean
square error of approximation (RMSEA)39 index, the
comparative ﬁt index (CFI)40 and the Tucker–Lewis Index
(TLI)41. All candidate models were also re-estimated
using full information maximum likelihood with robust
standard errors (MLR) to obtain Akaike Information
Criterion (AIC)42, Bayesian Information Criterion (BIC)43
and sample size adjusted BIC (ssaBIC) relative ﬁt mea-
sures. Due to the number of dimensions and, subse-
quently, the very large number of integration points
needed to estimate the models, we used WLSMV for all
subsequent association analyses as it was computationally
more efﬁcient when modelling ordinal data. To assess
model reliability, omega reliability coefﬁcients44 were
Table 1 Discovery study GWASs and number of SNPs used to generate PRSs for each trait of interest
Number of SNPs in each PRS
Trait Discovery study PT = 0.5 PT = 0.05 PT = 1e − 5 GWS
Schizophrenia 2014 PGC GWAS33 191,361 47,960 737 111
MDD 2016 Hyde et al. GWAS34 292,257 53,937 145 8
Neuroticism 2016 Smith et al. GWAS35 265,332 49,811 147 9
Bipolar disorder 2011 PGC GWAS36 114,262 22,154 34 4
SNPs single nucleotide polymorphisms, PRS polygenic risk score, PT discovery study trait association P-value threshold used to include SNPs in PRS, GWS independent
genome-wide signiﬁcant SNPs reported by discovery study, PGC Psychiatric Genomics Consortium, GWAS genome-wide association study, MDD major depressive
disorder
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calculated (see Supplementary Methods for further
detail).
Multivariate linear regression (i.e. modelling all out-
comes simultaneously) was used to examine the rela-
tionships between the standardized PRSs and
psychopathological factors in the correlated factors and
bifactor models. No covariates accounting for possible
population ancestry effects were included as ALSPAC has
previously been shown to have no signiﬁcant population
stratiﬁcation and genome-wide analyses with other
phenotypes indicate a low lambda45–48. Individuals were
included in the association analyses if they had responded
to at least four questions per psychopathology measure
and had genetic data available (N= 2863). As a sensitivity
analysis to correct for multiple testing, factor scores were
exported from Mplus and permutation-adjusted P-values
for associations with the PRSs were computed using R49
(Supplementary Table 4). We also investigated the
potential of bias within our analyses due to systematic
differences between our analysis sample (2863 individuals
Fig. 1 Measurement models developed to explore the dimensional structure of the items and the relationship between psychotic experiences (PE),
negative dimension (NEG), depression (DEP), anxiety (ANX) and general psychopathology (GENERAL). Boxes represent multiple individual items
relating to each domain. Each of these items would load onto a factor; however, for simplicity, only three arrows are shown emerging from each
factor
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with genetic and phenotypic data) and individuals not
included in our analyses (5389 individuals with genetic
data but no phenotypic data). To do this, we generated a
set of weighted results using inverse probability weighting
(IPW)50 (see Supplementary Methods for further detail).
Results
Model ﬁt
Modelling the data within a bifactor structure described
the data better than uncorrelated, unidimensional or
correlated factor structures, providing the lowest AIC,
BIC and ssaBIC values (Table 2). Both the correlated
factors and bifactor models showed excellent ﬁt across all
absolute ﬁt statistics (Table 2).
Although the model ﬁt statistics indicated that the
bifactor model provided the best ﬁt, bifactor models can
be difﬁcult to interpret and concerns have been raised that
they may over-ﬁt data by capturing unwanted noise as
well as construct relevant variance51. Therefore, we pre-
sent results for both the correlated and bifactor models in
the aim of adding robustness to our ﬁndings and to allow
for easier interpretation of the patterns of association
between genetic liability for schizophrenia, MDD, neu-
roticism and bipolar disorder and adolescent
psychopathology.
Item loadings, correlations and reliability
All items had standardized factor loadings >0.4 onto
their corresponding latent variables within the correlated
factors model (Supplementary Table 1). Correlations
between the four latent variables are shown in Supple-
mentary Table 5 and ranged from 0.410 (negative
dimension and anxiety) to 0.723 (negative dimension and
depression).
All negative dimension and depression item factor
loadings were highest for the general factor within the
bifactor model. In contrast, almost all psychotic experi-
ences and anxiety item factor loadings were highest for
their corresponding speciﬁc factors.
Omega reliability coefﬁcients are shown in Supplemen-
tary Table 1. The proportions of variance explained by the
speciﬁc factors once partialling out the general factor were
lower than the corresponding ωS estimates, especially for
the depression factor (ωS= 0.96; ωHS= 0.15) indicating
that the MFQ items contain little speciﬁc variance over
and above the general factor. However, the difference
between the share of the score variance as a result of all
factors and the general factor (ω= 0.97; ωH= 0.79) indi-
cates that a proportion of the score variance was as a result
of the four speciﬁc factors of the model.
Associations between PRSs and psychopathology
Results for PT ≤ 0.05 are shown in Fig. 2 and Table 3.
Note that all regression betas (β) represent a standard
deviation change in factor per standard deviation change
in PRS.
Schizophrenia PRS
When modelling adolescent psychopathology within a
correlated factors model, an increase in the schizophrenia
PRS was associated with an increase in all psychopathol-
ogy factors (psychotic experiences: β, 0.09; 95% CI,
0.03–0.14; P= 0.001; negative dimension: β, 0.09; 95%
CI, 0.04–0.13; P < 0.001; depression: β, 0.04; 95% CI,
0.00–0.08; P= 0.042; anxiety: β, 0.06; 95% CI, 0.01–0.10;
P= 0.018). When introducing the general psychopathol-
ogy factor within the bifactor model, the schizophrenia
PRS was associated with an increase in the negative
dimension factor (β, 0.07; 95% CI, 0.01–0.12; P= 0.012)
and general psychopathology factor (β, 0.06; 95% CI,
0.01–0.10; P= 0.014). There was weaker evidence that the
schizophrenia PRS was associated with an increase in the
psychotic experiences factor (β, 0.06; 95% CI, −0.01 to
0.13; P= 0.067), whilst no association with depression or
anxiety factors was observed.
Neuroticism PRS
There was evidence that an increase in the neuroticism
PRS was associated with an increase in the negative
dimension (β, 0.06; 95% CI, 0.02–0.10; P= 0.003),
depression (β, 0.06; 95% CI, 0.02–0.10; P= 0.007) and
anxiety (β, 0.08; 95% CI, 0.04–0.13; P < 0.001) latent fac-
tors within the correlated factors model. Within the
bifactor model, there was strong evidence that
Table 2 Model ﬁt statistics for the four measurement models (N= 3650)
Model Number of parameters AICa BICa ssaBICa RMSEA (90% CI) CFI TLI
Uncorrelated group factors 146 183486.4 184392.0 183928.0 0.091 (0.090, 0.091) 0.620 0.604
Unidimensional 146 188747.9 189653.5 189189.6 0.060 (0.059, 0.060) 0.835 0.828
Correlated group factors 152 180413.7 181356.5 180873.5 0.029 (0.028, 0.030) 0.961 0.959
Bifactor 197 179668.5 180890.4 180264.4 0.028 (0.027, 0.029) 0.965 0.962
AIC Akaike Information Criterion, BIC Bayesian Information Criterion, ssaBIC sample size adjusted Bayesian Information Criterion, RMSEA root mean square error of
approximation, CFI comparative ﬁt index, TLI Tucker–Lewis index
aEstimated using Monte Carlo integration with 8000 integration points
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neuroticism PRS was associated with an increase in the
general psychopathology factor (β, 0.07; 95% CI,
0.03–0.11; P= 0.001) and, although weaker, with an
increase in the anxiety factor (β, 0.05; 95% CI, 0.00–0.10;
P= 0.042). There was weak evidence that the neuroticism
PRS was associated with a decrease in the psychotic
experiences factor (β, −0.06; 95% CI, −0.12 to 0.01;
P= 0.080).
Bipolar disorder and MDD PRSs
The MDD PRS was weakly associated with depression
in the correlated factors model (β, 0.04; 95% CI, −0.00 to
0.08; P= 0.084) and with the general factor in the bifactor
model (β, 0.04; 95% CI, −0.00 to 0.09; P= 0.059). There
was no robust evidence of an association between psy-
chopathology factors and the bipolar disorder PRS when
modelled within a correlated factors or bifactor model.
Sensitivity analyses
Very similar results were observed for PRSs generated
using SNPs with a trait association of P ≤ 0.5. However,
results for PRSs derived using lower (1e−5 or genome-
wide level of association) P-value thresholds were more
inconsistent and did not follow any clear patterns across
sensitivity P-thresholds (Supplementary Figure 1; full
results available on request).
Interpretation of associations using permuted P-values
was substantively the same as above, with exception of the
associations between the schizophrenia PRS and psycho-
tic experiences, the neuroticism PRS and psychotic
experiences and anxiety, and the MDD PRS and the
general factor where the strength of evidence was now
considerably weaker (Supplementary Table 4).
A comparison of the IPW results to results without
weighting for potential bias due to missingness can be
found in Supplementary Tables 6 and 7. Estimates and
Fig. 2 Associations between latent traits for psychotic experiences (PE), negative dimension (NEG), depression (DEP), anxiety (ANX) and general
psychopathology (GENERAL) generated using a correlated factors model (a) and a bifactor model (b) and polygenic risk scores (PRS) for schizophrenia
(SCZ), major depressive disorder (MDD), neuroticism (NEU) and bipolar disorder (BIP) generated using lists of SNPs meeting a 0.05 P-value threshold.
Standard deviation (SD) changes in latent trait per SD change in PRS are shown with upper and lower 95% conﬁdence intervals. N= 2863
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standard errors of the association between PRSs and
psychopathology domains within the correlated
and bifactor models were similar between weighted and
unweighted analyses although the association between the
schizophrenia PRS and negative dimension within the
bifactor model was less robust (Supplementary Table 7).
Discussion
Correlated factors model
When modelling psychotic experiences, negative
dimension items, depression and anxiety as separate,
correlated, latent constructs (correlated factors model),
we found that genetic risk for schizophrenia was asso-
ciated with an increase in all four adolescent psycho-
pathology constructs. Schizophrenia PRS association
effect sizes were similar and conﬁdence intervals over-
lapped across all psychopathology factors. The smallest
effect size was for the association between the
schizophrenia PRS and depression which is consistent
with our previous publication using binary outcome
measures within this sample16. Our results from the
correlated factors model showing stronger evidence of
association with psychotic experiences compared to our
previous publication16, suggest that accounting for mea-
surement error through use of latent models might be
particularly important for these phenomena.
Bifactor model
Bifactor models have a number of advantages over
standard univariate approaches and are a popular
approach in modelling construct-relevant multi-
dimensionality52,53, improving psychiatric phenotype
deﬁnition and, in comparison to a summed-score
approach, can provide higher statistical power to detect
larger effect sizes54. Bifactor models have been used in
twin studies to decompose additive genetic and
Table 3 Associations between latent traits, generated using a correlated factors and bifactor model, and polygenic risk
scores (PRSs) for psychiatric disorders generated using lists of SNPs meeting a P-value threshold of 0.05
Correlated factors model Bifactor model
PRS trait Outcome βa LCI UCI P βa LCI UCI P
SCZ PE 0.087 0.034 0.140 0.001 0.062 −0.005 0.129 0.067
NEG 0.085 0.044 0.126 <0.001 0.066 0.013 0.119 0.012
DEP 0.043 0.002 0.084 0.042 −0.013 −0.074 0.048 0.670
ANX 0.055 0.010 0.100 0.018 0.029 −0.024 0.082 0.287
GENERAL – – – – 0.055 0.010 0.100 0.014
MDD PE −0.002 −0.055 0.051 0.933 −0.034 −0.099 0.031 0.293
NEG 0.019 −0.020 0.058 0.347 −0.026 −0.077 0.025 0.310
DEP 0.037 −0.004 0.078 0.084 -0.006 −0.069 0.057 0.859
ANX 0.029 −0.018 0.076 0.225 0.008 −0.047 0.063 0.774
GENERAL – – – – 0.043 −0.002 0.088 0.059
NEU PE −0.001 −0.054 0.052 0.972 −0.058 −0.123 0.007 0.080
NEG 0.059 0.020 0.098 0.003 0.001 −0.048 0.050 0.959
DEP 0.055 0.016 0.094 0.007 −0.024 −0.083 0.035 0.420
ANX 0.082 0.039 0.125 <0.001 0.052 0.001 0.103 0.042
GENERAL – – – – 0.071 0.028 0.114 0.001
BIP PE −0.039 −0.092 0.014 0.156 −0.023 −0.088 0.042 0.486
NEG −0.004 −0.045 0.037 0.841 0.033 −0.020 0.086 0.222
DEP −0.024 −0.065 0.017 0.264 0.013 −0.052 0.078 0.684
ANX −0.028 −0.075 0.019 0.243 −0.015 −0.068 0.038 0.576
GENERAL – – – – −0.030 −0.075 0.015 0.181
SCZ schizophrenia, MDD major depressive disorder, NEU neuroticism, BIP bipolar disorder, PE psychotic experience, NEG negative dimension, DEP depression, ANX
anxiety, GENERAL general psychopathology, LCI lower 95% conﬁdence interval, UCI upper 95% conﬁdence interval, P P-value for association between latent trait and
PRS
aStandardized estimate
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environmental effects across phenotypes55,56 and in a
cohort study to investigate associations with candidate
genes implicated in affective disorders54, but have not
been utilized previously to understand phenotypic mani-
festation of polygenic liability for psychiatric disorders as
far as we are aware.
The high correlation between the psychopathology
factors and large share of the score variance as a result of
the general factor (indicated by the omegas) suggest that
covariance between responses to items measuring psy-
chotic experiences, negative dimension, depression and
anxiety can be explained by an underlying general psy-
chopathology latent construct within the general popu-
lation, distinct from latent constructs speciﬁc for each
trait. In comparison to the correlated model results, there
was only weak evidence of association between schizo-
phrenia genetic risk and remaining variance for psychotic
experiences after accounting for the general psycho-
pathology factor. This suggests that psychotic experiences
resulting from higher genetic risk for schizophrenia
usually occur, at this age, in the presence of other psy-
chopathology too. This is perhaps not surprising; for
example, it is hard to imagine holding paranoid beliefs or
hearing hostile voices without some comorbid anxiety or
low mood.
The evidence of association between schizophrenia
genetic risk and remaining variance for anxiety, and
especially for depression, was even weaker when taking
into account the general psychopathology factor. How-
ever, there was stronger evidence of association with the
remaining variance relating to the negative dimension
items, although our IPW results suggest that this asso-
ciation might not be robust. This indicates that schizo-
phrenia genetic risk may manifest particularly strongly as
negative dimension traits in adolescence, above and
beyond the occurrence of general psychopathology, con-
ﬁrming our previous observation16. It is also possible that
risk variants for schizophrenia identiﬁed in the GWAS
may only weakly index risk for hallucinations and delu-
sions and more strongly reﬂect genetic risk for other
characteristics such as negative symptoms that index
severity or chronicity of illness and that might be selected
for in clinically ascertained samples57.
Interpretation in context of previous studies
Whilst family studies have shown that negative symp-
toms may have higher familial aggregation compared to
positive or depressive symptoms in people with schizo-
phrenia58, as yet there are no clear patterns of heritability
in clinical samples for phenotype dimensions as they are
currently conceived59,60. A population-based twin study of
trait psychopathology showed that self-reported anhedo-
nia and parent-rated negative symptoms were more
heritable than hallucinations, though no more heritable
than paranoia61. Our ﬁndings indicate that negative
dimension traits as well as other psychopathology during
adolescence, whilst not necessarily at levels of clinical
signiﬁcance, are indeed inﬂuenced by common genetic
variants that increase the risk for schizophrenia.
Other studies have examined the relationship between
schizophrenia genetic risk and psychopathology, both in
clinical and population-based samples. One study of
people with schizophrenia reported that polygenic risk
was associated with negative/disorganized factor scores
but not with positive symptom or mood dimensions62,
and more recently associations were reported between
genetic risk scores and both anxiety symptoms and gen-
eral psychopathology, but not with positive or negative
symptom dimensions, in patients with ﬁrst episode psy-
chosis63. Our correlated model ﬁndings are consistent
with associations reported with depression and anxiety in
ALSPAC and the Netherlands Twin Register64. Other
studies have not found evidence of associations between
schizophrenia genetic risk and dimensions of psycho-
pathology65,66, although statistical power may have been
limited due to the size of the discovery or target samples
used.
The lack of consistency of ﬁndings across studies to date
may be partly due to the difﬁculty of teasing out
psychopathology-speciﬁc effects from those that are
shared across symptom domains. By using a bifactor
modelling approach, our study is the ﬁrst to test whether
genetic risk is manifest as a common psychopathology, or
as speciﬁc symptoms related to one or more underlying
psychopathology constructs. Whilst we show that genetic
risk for schizophrenia is manifested primarily as general
psychopathology and possibly negative dimension traits, it
is possible that with greater power, for example from risk
scores derived using yet larger discovery samples, we
might also ﬁnd evidence of speciﬁc effects on psychotic
experiences, anxiety and depression above and beyond the
effect on general psychopathology. This might be difﬁcult,
however, as speciﬁc traits appear to offer very little
variability above that explained by general psychopathol-
ogy at this age. More detailed analyses, for example using
risk scores for speciﬁc sets of functionally related genes or
more detailed psychopathology items, might also allow us
to better understand the biological pathways that lead to
speciﬁc, as well as shared, psychopathology through use of
approaches such as latent trait modelling as we use here.
Genetic risk for MDD, neuroticism and bipolar disorder
We found no robust evidence of association between
the bipolar disorder genetic risk score and adolescent
psychopathology, though this might be due to the smaller
discovery sample used to derive PRSs for this phenotype
compared to those for schizophrenia, MDD and neuro-
ticism. As compared to the schizophrenia and
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neuroticism associations, the MDD PRS was only weakly
associated with the general factor which may be due to the
lower SNP-based heritability for MDD reported by the
GWAS used within the current study (0.06–0.07)34 as
compared to the other phenotypes.
We found that genetic risk for neuroticism was strongly
associated with anxiety, depression and negative dimen-
sion constructs within the correlated factors model but,
unlike our results for schizophrenia genetic risk, not with
psychotic experiences. Within the bifactor model, genetic
risk for neuroticism was strongly associated with the
general psychopathology construct, and less strongly with
the remaining variance for anxiety. Evidence for associa-
tion with remaining variance for negative dimension items
as well as that for psychotic experiences was weaker than
those for schizophrenia genetic risk, indicating that
genetic risk for schizophrenia may have a more speciﬁc
effect on these phenotypes than genetic risk for
neuroticism.
Strengths and limitations
The use of a large population-based sample with a
broad range of measures of psychopathology during
adolescence allows us to infer how genetic risk for psy-
chiatric disorders is likely manifested in the general
population at this age. However, whilst the ALSPAC
cohort is broadly representative of the UK population,
attrition and missing data means that selection bias might
have affected our results. Genetic risk for schizophrenia is
associated with increased likelihood of attrition67, and if
presence of psychopathology is also related to missingness
this could introduce collider bias in our results.
Whilst self-report measures may perform less well for
psychotic experiences than other psychopathological
domains, we used self-report measures as we wanted all
psychopathology domains assessed at similar ages using
questionnaire data, and we previously reported that asso-
ciations with schizophrenia genetic risk were consistent
when comparing self-report and interview-assessed psy-
chotic experiences16. Unfortunately, additional data were
not collected to ascertain the test–retest reliability of the
questionnaires used. We can therefore not assess whether
intra-individual variability in responses has biased our
results.
A strength of our study is that use of a latent modelling
framework allowed us to tease out the effects that explain
the shared variance across measures from those that are
speciﬁc to constructs separate from general psycho-
pathology. However, we do not know the source or rele-
vance of the speciﬁc-construct variance, particularly
where this has only modest speciﬁc variance over and
above the general factor, as for example, the negative
dimension construct. Furthermore, whilst the symptoms
assessed using the CAPE measure of negative symptoms
were derived from the Scale for Assessment of Negative
Symptoms and load onto a separate factor from depres-
sive symptoms in other studies29, as in ours, they might
not accurately index negative symptoms as con-
ceptualized in schizophrenia.
Furthermore, item contamination may have occurred,
whereby, for example, similarity in items between the 12-
item Eysenck Personality Questionnaire-Revised used to
generate the neuroticism PRS and the depression and
anxiety measures used in our study may have led to an
overestimate of association between the neuroticism PRS
and the general factor. However, a previous study iden-
tiﬁed a genetic overlap between neuroticism (negative
emotionality) and general psychopathology using an item
pool designed to exclude synonyms or antonyms of psy-
chopathology symptoms56, suggesting that such a bias is
unlikely to adequately explain our ﬁndings. Similarity in
question wording was also evident between the CAPE and
MFQ items used to construct the negative dimension of
psychosis and depression factors, respectively. For exam-
ple, both scales contain items relating to loss of motiva-
tion. This may explain their high correlation within the
correlated factors model.
The particular measures used in the current study may
also have introduced confounding by question time-
frames. Questions from two domains referred to past
month experiences, one to experiences in the past 2 weeks
and one to experiences since age 15 years. This may
reduce/increase the covariances between each pair of
latent factors and hence the degree of support for the
bifactor model.
Finally, our models do not include measures of exter-
nalizing psychopathology or cognition, thus limiting
comparison to the general factor in bifactor models that
have been derived in studies that have incorporated such
measures.
Conclusions
Psychopathologies experienced during adolescence
share common variance that may be captured by a
general psychopathology construct with remaining,
non-shared, variance representing what is distinct to
each speciﬁc symptom domain. Genetic risk for schi-
zophrenia is manifested primarily as general psycho-
pathology encompassing a mixture of psychotic,
negative dimension, anxiety and depressive symptoms,
along with potentially speciﬁc effects on negative
dimension items. GWAS of symptom dimensions uti-
lizing a latent modelling framework might be able to add
to our understanding of biological pathways that inﬂu-
ence speciﬁc phenotypes to a greater extent than GWAS
of schizophrenia per se, if power issues from the limited
sample sizes with rich phenotypic data could be
overcome.
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